BioCardia Inc.

NASDAQ: BCDA · Real-Time Price · USD
1.90
0.01 (0.53%)
At close: Aug 15, 2025, 3:59 PM
1.92
0.98%
After-hours: Aug 15, 2025, 07:42 PM EDT

BioCardia Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
58K 477K 1.35M 1.01M
Cost of Revenue
430K 411K 377K 640K
Gross Profit
-372K 66K 975K 375K
Operating Income
-8M -11.64M -11.9M -12.63M
Interest Income
n/a n/a n/a 9K
Pretax Income
-7.95M -11.57M -11.91M -12.62M
Net Income
-7.95M -11.57M -11.91M -12.62M
Selling & General & Admin
3.67M 4.39M 4.42M 5.09M
Research & Development
4.39M 7.73M 8.83M 8.56M
Other Expenses
-430K -411K -377K -640K
Operating Expenses
7.63M 11.71M 12.88M 13.01M
Interest Expense
n/a n/a 6K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
8.06M 12.12M 13.25M 13.64M
Income Tax Expense
n/a n/a 6K -2K
Shares Outstanding (Basic)
2.74M 1.41M 1.18M 1.13M
Shares Outstanding (Diluted)
2.74M 1.41M 1.18M 1.13M
EPS (Basic)
-2.9 -8.19 -10.05 -11.19
EPS (Diluted)
-2.9 -8.19 -10.05 -11.19
EBITDA
-7.93M -11.56M -11.82M -12.57M
EBIT
-8M -11.64M -11.9M -12.63M
Depreciation & Amortization
67K 84K 82K 60K